Camptocormia in Japanese patients with Parkinson's disease: A multicenter study

Morinobu Seki, Kazushi Takahashi, Atsuo Koto, Ban Mihara, Yoko Morita, Kazuo Isozumi, Kouichi Ohta, Kazuhiro Muramatsu, Jun Gotoh, Keiji Yamaguchi, Yutaka Tomita, Hideki Sato, Yoshihiro Nihei, Satoko Iwasawa, Norihiro Suzuki

研究成果: Article

30 引用 (Scopus)

抄録

Objective: The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients. Background: Although camptocormia has been recognized as a prominent phenomenon in PD, the previous epidemiological reports were limited, especially in terms of sample size. Methods:: We evaluated 531 PD patients (disease duration: 7.0 ± 5.5 years, mean ± standard deviation). We examined their clinical features and the prevalence of camptocormia. Results: Camptocormia was detected in 22 patients (4.1%) and found in patients who were older and had more severe motor symptoms and a higher levodopa (L-dopa) dose (P < 0.05), compared to the patients without camptocormia. Patients with camptocormia showed significantly higher frequencies of autonomic symptoms, such as constipation and urinary incontinence (P < 0.05). Conclusions: Camptocormia is uncommon in PD and is associated with disease severity, higher L-dopa dose and higher frequencies of autonomic symptoms.

元の言語English
ページ(範囲)2567-2571
ページ数5
ジャーナルMovement Disorders
26
発行部数14
DOI
出版物ステータスPublished - 2011 12

Fingerprint

Multicenter Studies
Parkinson Disease
Levodopa
Camptocormia
Urinary Incontinence
Constipation
Sample Size
Population

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

これを引用

Seki, M., Takahashi, K., Koto, A., Mihara, B., Morita, Y., Isozumi, K., ... Suzuki, N. (2011). Camptocormia in Japanese patients with Parkinson's disease: A multicenter study. Movement Disorders, 26(14), 2567-2571. https://doi.org/10.1002/mds.23955

Camptocormia in Japanese patients with Parkinson's disease : A multicenter study. / Seki, Morinobu; Takahashi, Kazushi; Koto, Atsuo; Mihara, Ban; Morita, Yoko; Isozumi, Kazuo; Ohta, Kouichi; Muramatsu, Kazuhiro; Gotoh, Jun; Yamaguchi, Keiji; Tomita, Yutaka; Sato, Hideki; Nihei, Yoshihiro; Iwasawa, Satoko; Suzuki, Norihiro.

:: Movement Disorders, 巻 26, 番号 14, 12.2011, p. 2567-2571.

研究成果: Article

Seki, M, Takahashi, K, Koto, A, Mihara, B, Morita, Y, Isozumi, K, Ohta, K, Muramatsu, K, Gotoh, J, Yamaguchi, K, Tomita, Y, Sato, H, Nihei, Y, Iwasawa, S & Suzuki, N 2011, 'Camptocormia in Japanese patients with Parkinson's disease: A multicenter study', Movement Disorders, 巻. 26, 番号 14, pp. 2567-2571. https://doi.org/10.1002/mds.23955
Seki M, Takahashi K, Koto A, Mihara B, Morita Y, Isozumi K その他. Camptocormia in Japanese patients with Parkinson's disease: A multicenter study. Movement Disorders. 2011 12;26(14):2567-2571. https://doi.org/10.1002/mds.23955
Seki, Morinobu ; Takahashi, Kazushi ; Koto, Atsuo ; Mihara, Ban ; Morita, Yoko ; Isozumi, Kazuo ; Ohta, Kouichi ; Muramatsu, Kazuhiro ; Gotoh, Jun ; Yamaguchi, Keiji ; Tomita, Yutaka ; Sato, Hideki ; Nihei, Yoshihiro ; Iwasawa, Satoko ; Suzuki, Norihiro. / Camptocormia in Japanese patients with Parkinson's disease : A multicenter study. :: Movement Disorders. 2011 ; 巻 26, 番号 14. pp. 2567-2571.
@article{1357a701edef4d0e8f09e459cb418b1a,
title = "Camptocormia in Japanese patients with Parkinson's disease: A multicenter study",
abstract = "Objective: The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients. Background: Although camptocormia has been recognized as a prominent phenomenon in PD, the previous epidemiological reports were limited, especially in terms of sample size. Methods:: We evaluated 531 PD patients (disease duration: 7.0 ± 5.5 years, mean ± standard deviation). We examined their clinical features and the prevalence of camptocormia. Results: Camptocormia was detected in 22 patients (4.1{\%}) and found in patients who were older and had more severe motor symptoms and a higher levodopa (L-dopa) dose (P < 0.05), compared to the patients without camptocormia. Patients with camptocormia showed significantly higher frequencies of autonomic symptoms, such as constipation and urinary incontinence (P < 0.05). Conclusions: Camptocormia is uncommon in PD and is associated with disease severity, higher L-dopa dose and higher frequencies of autonomic symptoms.",
keywords = "Bent spine, Camptocormia, Japanese patients, Nonmotor symptom, Parkinson's disease",
author = "Morinobu Seki and Kazushi Takahashi and Atsuo Koto and Ban Mihara and Yoko Morita and Kazuo Isozumi and Kouichi Ohta and Kazuhiro Muramatsu and Jun Gotoh and Keiji Yamaguchi and Yutaka Tomita and Hideki Sato and Yoshihiro Nihei and Satoko Iwasawa and Norihiro Suzuki",
year = "2011",
month = "12",
doi = "10.1002/mds.23955",
language = "English",
volume = "26",
pages = "2567--2571",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "14",

}

TY - JOUR

T1 - Camptocormia in Japanese patients with Parkinson's disease

T2 - A multicenter study

AU - Seki, Morinobu

AU - Takahashi, Kazushi

AU - Koto, Atsuo

AU - Mihara, Ban

AU - Morita, Yoko

AU - Isozumi, Kazuo

AU - Ohta, Kouichi

AU - Muramatsu, Kazuhiro

AU - Gotoh, Jun

AU - Yamaguchi, Keiji

AU - Tomita, Yutaka

AU - Sato, Hideki

AU - Nihei, Yoshihiro

AU - Iwasawa, Satoko

AU - Suzuki, Norihiro

PY - 2011/12

Y1 - 2011/12

N2 - Objective: The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients. Background: Although camptocormia has been recognized as a prominent phenomenon in PD, the previous epidemiological reports were limited, especially in terms of sample size. Methods:: We evaluated 531 PD patients (disease duration: 7.0 ± 5.5 years, mean ± standard deviation). We examined their clinical features and the prevalence of camptocormia. Results: Camptocormia was detected in 22 patients (4.1%) and found in patients who were older and had more severe motor symptoms and a higher levodopa (L-dopa) dose (P < 0.05), compared to the patients without camptocormia. Patients with camptocormia showed significantly higher frequencies of autonomic symptoms, such as constipation and urinary incontinence (P < 0.05). Conclusions: Camptocormia is uncommon in PD and is associated with disease severity, higher L-dopa dose and higher frequencies of autonomic symptoms.

AB - Objective: The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients. Background: Although camptocormia has been recognized as a prominent phenomenon in PD, the previous epidemiological reports were limited, especially in terms of sample size. Methods:: We evaluated 531 PD patients (disease duration: 7.0 ± 5.5 years, mean ± standard deviation). We examined their clinical features and the prevalence of camptocormia. Results: Camptocormia was detected in 22 patients (4.1%) and found in patients who were older and had more severe motor symptoms and a higher levodopa (L-dopa) dose (P < 0.05), compared to the patients without camptocormia. Patients with camptocormia showed significantly higher frequencies of autonomic symptoms, such as constipation and urinary incontinence (P < 0.05). Conclusions: Camptocormia is uncommon in PD and is associated with disease severity, higher L-dopa dose and higher frequencies of autonomic symptoms.

KW - Bent spine

KW - Camptocormia

KW - Japanese patients

KW - Nonmotor symptom

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=83555176389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83555176389&partnerID=8YFLogxK

U2 - 10.1002/mds.23955

DO - 10.1002/mds.23955

M3 - Article

C2 - 21953897

AN - SCOPUS:83555176389

VL - 26

SP - 2567

EP - 2571

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 14

ER -